Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

New York ,United States ,Illinois ,Alexandria ,Al Iskandariyah ,Egypt ,Rockefeller University ,Chicago ,American ,Masoud Tavazoie ,Maeve Conneighton ,Andrew Hendifar ,Sinai Medical Center ,American Society Of Clinical Oncology ,Alexandria Venture Investments ,Lepu Holdings ,Inspirna Inc ,Wuxi Pharmatech Healthcare Fund ,Partnership Fund For New York City ,Novo Holdings ,Clinical Oncology ,Annual Meeting ,Assistant Professor ,Cedars Sinai Medical Center ,Chief Executive Officer ,Gastrointestinal Cancer ,Sofinnova Partners ,Lepu Holdings Limited ,Sixty Degree Capital ,Oceanpine Capital ,Exor Seeds ,Partnership Fund ,Business Wire ,Health ,Cancer ,Clinical Trials ,